finanznachrichten.de
Negativewww.finanznachrichten.de ·
68435555 odyssey therapeutics prices upsized ipo of 15 50 mln shares at dollar 18 shr 020
TradeFinancial Sector DevelopmentCapital MarketsStockmarket
Topic context
This topic has been covered 143361 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedOdyssey Therapeutics, a biotech company, completed an upsized IPO raising ~$304 million. The capital infusion supports its drug development pipeline. No specific product or commercial mechanism beyond equity financing; impact is limited to the company's own cash position and R&D spending. No direct commodity, supply chain, or margin squeeze identified.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Odyssey Therapeutics upsized IPO to 15.50 million shares at $18.00 per share.
- Underwriters have option to purchase an additional 2.33 million shares.
- Private placement of ~1.39 million shares to TPG Life Sciences Innovations at $18.00.
- Total gross proceeds expected ~$304 million from IPO and private placement.
- Ticker ODTX, trading on Nasdaq Capital Market starting May 8, 2026.
